Prescription drug · ANDA
Clorazepate Dipotassium NDC 72789-256
Clorazepate dipotassium 15 mg/1 · Tablet · Oral · PD-Rx Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72789-256-06 | 7278902560672789025606 | 6 TABLET in 1 BOTTLE, PLASTIC (72789-256-06)Marketed from Jul 1, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clorazepate Dipotassium
- Generic name (nonproprietary)
- clorazepate dipotassium
- Active ingredients
- Clorazepate dipotassium — 15 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- PD-Rx Pharmaceuticals, Inc.NDC labeler code 72789
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075731
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 72789-256_5b75e3f8-3582-2951-e063-6394a90acef9SPL ID 5b75e3f8-3582-2951-e063-6394a90acef9
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472789025606followed by a unit qualifier and the quantityPackage 72789-0256-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 72789-256
- What is NDC 72789-256?
- 72789-256 is the product NDC for Clorazepate Dipotassium, Clorazepate dipotassium 15 mg/1 tablet, listed with the FDA by PD-Rx Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Clorazepate Dipotassium.
- What is the active ingredient?
- Clorazepate dipotassium.
- Who is the labeler?
- PD-Rx Pharmaceuticals, Inc., NDC labeler code 72789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Clorazepate Dipotassium?
- 24 other product NDCs are listed under this name. See all Clorazepate Dipotassium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Clorazepate Dipotassium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | Coupler LLC | 67046-1601 | 67046-1601-03 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Coupler LLC | 67046-1462 | 67046-1462-03 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Coupler LLC | 67046-1501 | 67046-1501-03 |
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/1 | TabletOral | Aurolife Pharma LLC | 13107-282 | 13107-0282-0113107-0282-05 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | Aurolife Pharma LLC | 13107-283 | 13107-0283-0113107-0283-05 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Aurolife Pharma LLC | 13107-284 | 13107-0284-01 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 70954-157 | 70954-0157-1070954-0157-2070954-0157-40 |
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-112 | 72603-0112-0172603-0112-02 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-113 | 72603-0113-0172603-0113-02 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-114 | 72603-0114-01 |
Other NDCs under ANDA 075731
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 51672-4042 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 51672-4043 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 51672-4044 |
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/1 | TabletOral | Clinical Solutions Wholesale, LLC | 58118-4042 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | Clinical Solutions Wholesale, LLC | 58118-4043 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Clinical Solutions Wholesale, LLC | 58118-4044 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | Coupler LLC | 67046-1501 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | Coupler LLC | 67046-1601 |
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-112 |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-113 |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/1 | TabletOral | NORTHSTAR RX LLC | 72603-114 |